AHA requests assistance, guidance for behavioral health providers

Apr 09, 2020 - 04:34 PM

Providers caring for patients with behavioral health disorders face unique challenges in balancing safe public health measures and clinical protocols during the COVID-19 emergency, the AHA today said in a letter to Health and Human Services Secretary Alex Azar.

Specifically, AHA requested guidance on how to apply general guidelines around COVID-19 for this vulnerable patient population, including specialized guidance for inpatient psychiatric facilities, and on providing additional services such as medication management and use of telehealth modalities.

It also urged the agency to ensure behavioral health services are appropriately reimbursed and behavioral health clinicians and professionals can receive emergency medical supplies and priority testing; relax staffing ratio requirements and certain restrictions on what tasks practitioners may perform; and preemptively plan for the likely surge of behavioral health patients that will follow the COVID-19 pandemic.

Related News Articles

Headline
FDA announces labeling changes to opioid pain medications 
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Senate committee advances appropriations bill
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Chairperson's File
Chair File: The OBBBA and What’s Next for Health Care
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…
Headline
Senate HELP Committee approves HHS assistant director nominee
The Senate Health, Education, Labor and Pensions Committee yesterday voted 12-11 along party lines to recommend the confirmation of Brian Christine, M.D., to…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Chairperson's File
Chair File: Leadership Dialogue — Continuing the Work to Strengthen Health in America With AHA President and CEO Rick Pollack
Public
This month Congress enacted the One Big Beautiful Bill Act — a sweeping package that contained many of President Trump’s legislative priorities on taxes,…